These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
778 related articles for article (PubMed ID: 32019578)
1. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer. Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578 [TBL] [Abstract][Full Text] [Related]
2. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity. Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083 [TBL] [Abstract][Full Text] [Related]
3. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer. He HJ; Gu XF; Xu WH; Yang DJ; Wang XM; Su Y Acta Pharmacol Sin; 2013 Feb; 34(2):282-8. PubMed ID: 23023312 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models. Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068 [TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells. Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046 [TBL] [Abstract][Full Text] [Related]
6. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
7. SIRT7 depletion inhibits cell proliferation, migration, and increases drug sensitivity by activating p38MAPK in breast cancer cells. Chen KL; Li L; Yang FX; Li CM; Wang YR; Wang GL J Cell Physiol; 2018 Sep; 233(9):6767-6778. PubMed ID: 29231244 [TBL] [Abstract][Full Text] [Related]
8. Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo. Thomas C; Zoubeidi A; Kuruma H; Fazli L; Lamoureux F; Beraldi E; Monia BP; MacLeod AR; Thüroff JW; Gleave ME Mol Cancer Ther; 2011 Feb; 10(2):347-59. PubMed ID: 21216933 [TBL] [Abstract][Full Text] [Related]
9. The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells. Huo C; Kuo YY; Lin CY; Shiah SG; Li CY; Huang SP; Chen JK; Wang WC; Kung HJ; Chuu CP Cancer Med; 2024 Aug; 13(16):e70106. PubMed ID: 39149855 [TBL] [Abstract][Full Text] [Related]
10. Endothelial cells promote metastasis of prostate cancer by enhancing autophagy. Zhao R; Bei X; Yang B; Wang X; Jiang C; Shi F; Wang X; Zhu Y; Jing Y; Han B; Xia S; Jiang Q J Exp Clin Cancer Res; 2018 Sep; 37(1):221. PubMed ID: 30200999 [TBL] [Abstract][Full Text] [Related]
11. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression. Chou FJ; Chen Y; Chen D; Niu Y; Li G; Keng P; Yeh S; Chang C EBioMedicine; 2019 Feb; 40():504-516. PubMed ID: 30692044 [TBL] [Abstract][Full Text] [Related]
12. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer. Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391 [TBL] [Abstract][Full Text] [Related]
13. Regulation of androgen receptor expression by Z-isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer. Liu PY; Lin SZ; Sheu JJ; Lin CT; Lin PC; Chou YW; Huang MH; Chiou TW; Harn HJ Prostate; 2013 Apr; 73(5):531-41. PubMed ID: 23038474 [TBL] [Abstract][Full Text] [Related]
14. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades. Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z Life Sci; 2020 May; 248():117449. PubMed ID: 32088212 [TBL] [Abstract][Full Text] [Related]
15. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression. Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108 [TBL] [Abstract][Full Text] [Related]
16. Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics. Hu B; Wang C; Wu Y; Han C; Liu J; Chen R; Wang T J Ethnopharmacol; 2024 Aug; 330():118228. PubMed ID: 38643863 [TBL] [Abstract][Full Text] [Related]
17. β Zhang M; Wang Q; Sun X; Yin Q; Chen J; Xu L; Xu C Prostate; 2020 Nov; 80(15):1328-1340. PubMed ID: 32894788 [TBL] [Abstract][Full Text] [Related]
18. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells. He J; Lan X; Duan HL; Luo H; Zhou XD Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677 [TBL] [Abstract][Full Text] [Related]
19. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5. Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Yu H; Ye W; Wu J; Meng X; Liu RY; Ying X; Zhou Y; Wang H; Pan C; Huang W Clin Cancer Res; 2014 Jul; 20(13):3434-45. PubMed ID: 24771643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]